Today, biopharmaceutical company MapLight Therapeutics announced encouraging results from a Phase 2 trial testing a new investigational treatment for schizophrenia. The medication met its main goal, showing a statistically significant and clinically meaningful improvement in psychiatric symptoms compared to placebo — along with an early, promising signal on cognitive function, an area that's historically been hard to treat. It's good news. And it's a reminder of something we
Supporting someone with schizophrenia can make a huge difference in their well-being. It can feel overwhelming at times, but there are clear ways you can help while also looking after yourself.
Here are practical, schizophrenia-specific ways to get through the holidays with less stress and lower relapse risk. I’m aiming for tools you can actually use, not “just be positive” fluff.
